Patent · US Active

Automated production of viral vectors

US12180511B2 · kind B2 · utility

0Cited by
50References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 2023
Grant dateDec 31, 2024
Priority date
Expiry dateJun 20, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/006
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides an automated method of producing viral vectors, utilizing engineered viral vector-producing cell lines within a fully-enclosed cell engineering system. Exemplary viral vectors that can be produced include lentivirus vectors, adeno-associated virus vectors, baculovirus vectors and retrovirus vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.